−0.045CAD
−9.24 MCAD
334.18 KCAD
106.83 M
About APPILI THERAPEUTICS INC
Sector
CEO
Don Cilla
Headquarters
Halifax
Website
Employees (FY)
9
Founded
2015
ISIN
CA03783R1073
FIGI
BBG00PH28MD0
Appili Therapeutics, Inc. is a pharmaceutical company, which acquires and develops novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as ATI-1501, ATI-1503, and ATI-1701. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of APLI is 0.035 CAD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NEO exchange APPILI THERAPEUTICS INC stocks are traded under the ticker APLI.
APPILI THERAPEUTICS INC is going to release the next earnings report on Jun 21, 2024. Keep track of upcoming events with our Earnings Calendar.
APLI stock is 0% volatile and has beta coefficient of −0.63. Check out the list of the most volatile stocks — is APPILI THERAPEUTICS INC there?
One year price forecast for APPILI THERAPEUTICS INC has a max estimate of 0.250 CAD and a min estimate of 0.250 CAD.
APLI earnings for the last quarter are −0.01 CAD per share, whereas the estimation was −0.02 CAD resulting in a 50.00% surprise. The estimated earnings for the next quarter are −0.01 CAD per share. See more details about APPILI THERAPEUTICS INC earnings.
Yes, you can track APPILI THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
APLI stock has fallen by 22.22% compared to the previous week, the last month showed zero change in price, over the last year APPILI THERAPEUTICS INC has showed a 22.22% decrease.
APLI net income for the last quarter is −152.34 K CAD, while the quarter before that showed −976.56 K CAD of net income which accounts for 84.40% change. Track more APPILI THERAPEUTICS INC financial stats to get the full picture.
Today APPILI THERAPEUTICS INC has the market capitalization of 4.24 M, it has decreased by 10.00% over the last week.
No, APLI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, APLI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APPILI THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 9.00 employees. See our rating of the largest employees — is APPILI THERAPEUTICS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So APPILI THERAPEUTICS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating APPILI THERAPEUTICS INC stock shows the sell signal. See more of APPILI THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on APPILI THERAPEUTICS INC future price: according to them, APLI price has a max estimate of 0.25 CAD and a min estimate of 0.25 CAD. Read a more detailed APPILI THERAPEUTICS INC forecast: see what analysts think of APPILI THERAPEUTICS INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. APPILI THERAPEUTICS INC EBITDA is −7.85 M CAD, and current EBITDA margin is −2.28 K%. See more stats in APPILI THERAPEUTICS INC financial statements.